Back to Newsroom

Curis Reports Second Quarter 2017 Financial Results

LEXINGTON, Mass., Aug. 03, 2017 (GLOBE NEWSWIRE) — Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers, reported today its financial results for the second quarter ended June 30, 2017.